Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 106 Pages
Report ld: 3499384
Request Sample
Customized Report
Polysaccharide Hemostatic Powder Market Size(US$)

CAGR 2025-2031
7.8%
Market Size,2031
USD 451
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Polysaccharide Hemostatic Powder is an innovative hemostatic product formulated primarily with natural polysaccharides, known for their ability to promote blood clotting and wound healing. As awareness of health and a demand for natural and safe products continue to rise, the market has shown a significant interest in Polysaccharide Hemostatic Powder. Its distinctive hemostatic mechanism and low irritability make it an ideal choice in fields such as surgical procedures, trauma management, and emergency care. In recent years, the clinical efficacy of Polysaccharide Hemostatic Powder has been well-documented, gradually establishing it as a trusted option among medical institutions and consumers alike.
This report aims to provide a comprehensive presentation of the global market for Polysaccharide Hemostatic Powder, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polysaccharide Hemostatic Powder by region & country, by Type, and by Application.
The Polysaccharide Hemostatic Powder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polysaccharide Hemostatic Powder.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polysaccharide Hemostatic Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Polysaccharide Hemostatic Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Polysaccharide Hemostatic Powder in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Polysaccharide Hemostatic Powder Product Introduction
1.2 Global Polysaccharide Hemostatic Powder Market Size Forecast
1.2.1 Global Polysaccharide Hemostatic Powder Sales Value (2020-2031)
1.2.2 Global Polysaccharide Hemostatic Powder Sales Volume (2020-2031)
1.2.3 Global Polysaccharide Hemostatic Powder Sales Price (2020-2031)
1.3 Polysaccharide Hemostatic Powder Market Trends & Drivers
1.3.1 Polysaccharide Hemostatic Powder Industry Trends
1.3.2 Polysaccharide Hemostatic Powder Market Drivers & Opportunity
1.3.3 Polysaccharide Hemostatic Powder Market Challenges
1.3.4 Polysaccharide Hemostatic Powder Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polysaccharide Hemostatic Powder Players Revenue Ranking (2024)
2.2 Global Polysaccharide Hemostatic Powder Revenue by Company (2020-2025)
2.3 Global Polysaccharide Hemostatic Powder Players Sales Volume Ranking (2024)
2.4 Global Polysaccharide Hemostatic Powder Sales Volume by Company Players (2020-2025)
2.5 Global Polysaccharide Hemostatic Powder Average Price by Company (2020-2025)
2.6 Key Manufacturers Polysaccharide Hemostatic Powder Manufacturing Base and Headquarters
2.7 Key Manufacturers Polysaccharide Hemostatic Powder Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Polysaccharide Hemostatic Powder
2.9 Polysaccharide Hemostatic Powder Market Competitive Analysis
2.9.1 Polysaccharide Hemostatic Powder Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Polysaccharide Hemostatic Powder Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polysaccharide Hemostatic Powder as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Polysaccharide Hemostatic Powder
3.1.2 Absorbable Modified Polymer
3.2 Global Polysaccharide Hemostatic Powder Sales Value by Type
3.2.1 Global Polysaccharide Hemostatic Powder Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Polysaccharide Hemostatic Powder Sales Value, by Type (2020-2031)
3.2.3 Global Polysaccharide Hemostatic Powder Sales Value, by Type (%) (2020-2031)
3.3 Global Polysaccharide Hemostatic Powder Sales Volume by Type
3.3.1 Global Polysaccharide Hemostatic Powder Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Polysaccharide Hemostatic Powder Sales Volume, by Type (2020-2031)
3.3.3 Global Polysaccharide Hemostatic Powder Sales Volume, by Type (%) (2020-2031)
3.4 Global Polysaccharide Hemostatic Powder Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Polysaccharide Hemostatic Powder Sales Value by Application
4.2.1 Global Polysaccharide Hemostatic Powder Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Polysaccharide Hemostatic Powder Sales Value, by Application (2020-2031)
4.2.3 Global Polysaccharide Hemostatic Powder Sales Value, by Application (%) (2020-2031)
4.3 Global Polysaccharide Hemostatic Powder Sales Volume by Application
4.3.1 Global Polysaccharide Hemostatic Powder Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Polysaccharide Hemostatic Powder Sales Volume, by Application (2020-2031)
4.3.3 Global Polysaccharide Hemostatic Powder Sales Volume, by Application (%) (2020-2031)
4.4 Global Polysaccharide Hemostatic Powder Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Polysaccharide Hemostatic Powder Sales Value by Region
5.1.1 Global Polysaccharide Hemostatic Powder Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Polysaccharide Hemostatic Powder Sales Value by Region (2020-2025)
5.1.3 Global Polysaccharide Hemostatic Powder Sales Value by Region (2026-2031)
5.1.4 Global Polysaccharide Hemostatic Powder Sales Value by Region (%), (2020-2031)
5.2 Global Polysaccharide Hemostatic Powder Sales Volume by Region
5.2.1 Global Polysaccharide Hemostatic Powder Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Polysaccharide Hemostatic Powder Sales Volume by Region (2020-2025)
5.2.3 Global Polysaccharide Hemostatic Powder Sales Volume by Region (2026-2031)
5.2.4 Global Polysaccharide Hemostatic Powder Sales Volume by Region (%), (2020-2031)
5.3 Global Polysaccharide Hemostatic Powder Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Polysaccharide Hemostatic Powder Sales Value, 2020-2031
5.4.2 North America Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Polysaccharide Hemostatic Powder Sales Value, 2020-2031
5.5.2 Europe Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Polysaccharide Hemostatic Powder Sales Value, 2020-2031
5.6.2 Asia Pacific Polysaccharide Hemostatic Powder Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Polysaccharide Hemostatic Powder Sales Value, 2020-2031
5.7.2 South America Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Polysaccharide Hemostatic Powder Sales Value, 2020-2031
5.8.2 Middle East & Africa Polysaccharide Hemostatic Powder Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value
6.2.1 Key Countries/Regions Polysaccharide Hemostatic Powder Sales Value, 2020-2031
6.2.2 Key Countries/Regions Polysaccharide Hemostatic Powder Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Polysaccharide Hemostatic Powder Sales Value, 2020-2031
6.3.2 United States Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Polysaccharide Hemostatic Powder Sales Value, 2020-2031
6.4.2 Europe Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Polysaccharide Hemostatic Powder Sales Value, 2020-2031
6.5.2 China Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
6.5.3 China Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Polysaccharide Hemostatic Powder Sales Value, 2020-2031
6.6.2 Japan Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Polysaccharide Hemostatic Powder Sales Value, 2020-2031
6.7.2 South Korea Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Polysaccharide Hemostatic Powder Sales Value, 2020-2031
6.8.2 Southeast Asia Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Polysaccharide Hemostatic Powder Sales Value, 2020-2031
6.9.2 India Polysaccharide Hemostatic Powder Sales Value by Type (%), 2024 VS 2031
6.9.3 India Polysaccharide Hemostatic Powder Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 EndoClot Plus
7.1.1 EndoClot Plus Company Information
7.1.2 EndoClot Plus Introduction and Business Overview
7.1.3 EndoClot Plus Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 EndoClot Plus Polysaccharide Hemostatic Powder Product Offerings
7.1.5 EndoClot Plus Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Baxter Polysaccharide Hemostatic Powder Product Offerings
7.2.5 Baxter Recent Development
7.3 Hemostasis, LLC
7.3.1 Hemostasis, LLC Company Information
7.3.2 Hemostasis, LLC Introduction and Business Overview
7.3.3 Hemostasis, LLC Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Hemostasis, LLC Polysaccharide Hemostatic Powder Product Offerings
7.3.5 Hemostasis, LLC Recent Development
7.4 Singclean Medical Products
7.4.1 Singclean Medical Products Company Information
7.4.2 Singclean Medical Products Introduction and Business Overview
7.4.3 Singclean Medical Products Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Singclean Medical Products Polysaccharide Hemostatic Powder Product Offerings
7.4.5 Singclean Medical Products Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Information
7.5.2 Johnson & Johnson Introduction and Business Overview
7.5.3 Johnson & Johnson Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Johnson & Johnson Polysaccharide Hemostatic Powder Product Offerings
7.5.5 Johnson & Johnson Recent Development
7.6 BD
7.6.1 BD Company Information
7.6.2 BD Introduction and Business Overview
7.6.3 BD Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 BD Polysaccharide Hemostatic Powder Product Offerings
7.6.5 BD Recent Development
7.7 Zhonghui Shengxi
7.7.1 Zhonghui Shengxi Company Information
7.7.2 Zhonghui Shengxi Introduction and Business Overview
7.7.3 Zhonghui Shengxi Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Zhonghui Shengxi Polysaccharide Hemostatic Powder Product Offerings
7.7.5 Zhonghui Shengxi Recent Development
7.8 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd.
7.8.1 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Company Information
7.8.2 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Introduction and Business Overview
7.8.3 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Polysaccharide Hemostatic Powder Product Offerings
7.8.5 Beijing Tech-Bio-Med Medical Equipment Co.,Ltd. Recent Development
7.9 Saikesaisi Holdings Group
7.9.1 Saikesaisi Holdings Group Company Information
7.9.2 Saikesaisi Holdings Group Introduction and Business Overview
7.9.3 Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Saikesaisi Holdings Group Polysaccharide Hemostatic Powder Product Offerings
7.9.5 Saikesaisi Holdings Group Recent Development
7.10 Boz Medical
7.10.1 Boz Medical Company Information
7.10.2 Boz Medical Introduction and Business Overview
7.10.3 Boz Medical Polysaccharide Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Boz Medical Polysaccharide Hemostatic Powder Product Offerings
7.10.5 Boz Medical Recent Development
8 Industry Chain Analysis
8.1 Polysaccharide Hemostatic Powder Industrial Chain
8.2 Polysaccharide Hemostatic Powder Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Polysaccharide Hemostatic Powder Sales Model
8.5.2 Sales Channel
8.5.3 Polysaccharide Hemostatic Powder Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 287 million in 2025 and is projected to reach US$ 483 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 128
USD 3950.00
(Single User License)
The global Polysaccharide Hemostatic Powder market was valued at US$ 287 million in 2025 and is anticipated to reach US$ 483 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 110
USD 2900.00
(Single User License)
The global Polysaccharide Hemostatic Powder market size was US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 77
USD 4250.00
(Single User License)
The global Polysaccharide Hemostatic Powder market is projected to grow from US$ 269 million in 2024 to US$ 451 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 150
USD 4900.00
(Single User License)
The global market for Polysaccharide Hemostatic Powder was valued at US$ 269 million in the year 2024 and is projected to reach a revised size of US$ 451 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-01-13
Pages: 80
USD 2900.00
(Single User License)
A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.
Published Date: 2024-01-17
Pages: 91
USD 2900.00
(Single User License)
The global market for Polysaccharide Hemostatic Powder was estimated to be worth US$ 287 million in 2025 and is projected to reach US$ 483 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 128
The global Polysaccharide Hemostatic Powder market was valued at US$ 287 million in 2025 and is anticipated to reach US$ 483 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-04-17
Pages: 110
The global Polysaccharide Hemostatic Powder market size was US$ 269 million in 2024 and is forecast to a readjusted size of US$ 451 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 77
The global Polysaccharide Hemostatic Powder market is projected to grow from US$ 269 million in 2024 to US$ 451 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 150
The global market for Polysaccharide Hemostatic Powder was valued at US$ 269 million in the year 2024 and is projected to reach a revised size of US$ 451 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-01-13
Pages: 80
A polysaccharide hemostatic powder can be used as an adjunctive hemostat to facilitate control of bleeding from capillary, venous or arteriolar vessels to address low-grade intraoperative bleeding.
Published: 2024-01-17
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now